Biggest News Aggregation in the World
📰 Primary Peritoneal News

Primary Peritoneal News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Primary Peritoneal. Real-time updates on events, politics, business and more.

ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Results from MIRASOL Also Show ELAHERE is the First Treatment to Demonstrate an Overall Survival Benefit in a Phase 3 Trial in Platinum-Resistant Ovarian Cancer Compared to Chemotherapy Clinically... | June 4, 2023
United States University Of Oklahoma David Omalley Kathleen Moore Pivekimab Sunirine Mirvetuximab Soravtansine

OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer

OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer - read this article along with other careers information, tips and advice on BioSpace
Ashleyr Robinson Kathleen Moore Laura Benjamin University Of Oklahoma Lifesci Partners Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science